# Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole

> **NCT05191628** · PHASE2 · TERMINATED · sponsor: **TBF Genie Tissulaire** · enrollment: 12 (actual)

## Conditions studied

- Macular Holes
- Retinal Detachment

## Interventions

- **BIOLOGICAL:** Visio-AMTRIX

## Key facts

- **NCT ID:** NCT05191628
- **Lead sponsor:** TBF Genie Tissulaire
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** TERMINATED
- **Start date:** 2020-06-10
- **Primary completion:** 2022-10-10
- **Final completion:** 2022-10-10
- **Target enrollment:** 12 (ACTUAL)
- **Why stopped:** Low accrual rate
- **Last updated:** 2023-05-01


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05191628

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05191628, "Amniotic Membrane Visio-AMTRIX in Recurrent Macular Hole". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT05191628. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*